Kura Oncology (KURA) Gains from Investment Securities (2014 - 2025)
Kura Oncology (KURA) reported Gains from Investment Securities of $1.0 million for Q4 2025, down 92.14% year-over-year from $12.9 million in Q4 2024, and up 4.6% on a QoQ basis from $969417.0 in Q3 2025.
Kura Oncology (KURA) has 12 years of Gains from Investment Securities data on file, last reported at $1.0 million in Q4 2025.
- Quarterly Gains from Investment Securities fell 92.14% year-over-year to $1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 million (down 92.14% YoY) and the FY2025 annual result came in at $1.0 million, down 92.14% from the prior year.
- Gains from Investment Securities rose to $1.0 million in Q4 2025 per KURA's latest filing, from $969417.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $12.9 million in Q4 2024 and bottomed at -$432000.0 in Q3 2021.
- The 5-year median for Gains from Investment Securities is $991708.5 (2025), against an average of $2.3 million.
- The widest annual swing landed in 2021, when Gains from Investment Securities tumbled 156.25%; it then jumped 1010.79% in 2023.
- Tracing KURA's Gains from Investment Securities over 5 years: stood at $2.7 million in 2021, then tumbled by 66.03% to $927000.0 in 2022, then jumped by 1010.79% to $10.3 million in 2023, then climbed by 25.31% to $12.9 million in 2024, then plunged by 92.14% to $1.0 million in 2025.
- Per Business Quant, the three latest KURA Gains from Investment Securities figures stand at $1.0 million (Q4 2025), $969417.0 (Q3 2025), and $1.2 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.01 Mn |
| Dec 31, 2025 | 1.01 Mn |
| Sep 30, 2025 | 969,417.00 |
| Sep 30, 2025 | 969,417.00 |
| Jun 30, 2025 | 1.16 Mn |
| Jun 30, 2025 | 1.16 Mn |
| Mar 31, 2025 | 1.16 Mn |
| Mar 31, 2025 | 1.16 Mn |
| Dec 31, 2024 | 12.90 Mn |
| Dec 31, 2024 | 12.90 Mn |
| Dec 31, 2023 | 10.30 Mn |
| Dec 31, 2023 | 10.30 Mn |
| Dec 31, 2022 | 927,000.00 |
| Dec 31, 2022 | 927,000.00 |
| Sep 30, 2022 | -231,000.00 |
| Sep 30, 2022 | -231,000.00 |
| Jun 30, 2022 | 110,000.00 |
| Jun 30, 2022 | 110,000.00 |
| Mar 31, 2022 | -105,000.00 |
| Mar 31, 2022 | -105,000.00 |
| Dec 31, 2021 | 2.73 Mn |
| Dec 31, 2021 | 2.73 Mn |
| Sep 30, 2021 | -432,000.00 |
| Sep 30, 2021 | -432,000.00 |
| Jun 30, 2021 | 1.59 Mn |
| Jun 30, 2021 | 1.59 Mn |
| Mar 31, 2021 | -410,000.00 |
| Mar 31, 2021 | -410,000.00 |
| Dec 31, 2020 | 14.18 Mn |
| Dec 31, 2020 | 14.18 Mn |
| Sep 30, 2020 | -299,000.00 |
| Sep 30, 2020 | -299,000.00 |
| Jun 30, 2020 | -373,000.00 |
| Jun 30, 2020 | -373,000.00 |
| Mar 31, 2020 | -160,000.00 |
| Mar 31, 2020 | -160,000.00 |
| Dec 31, 2019 | 30,000.00 |
| Dec 31, 2019 | 30,000.00 |
| Sep 30, 2019 | -128,000.00 |
| Sep 30, 2019 | -128,000.00 |
| Jun 30, 2019 | 33,000.00 |
| Jun 30, 2019 | 33,000.00 |
| Mar 31, 2019 | 182,000.00 |
| Mar 31, 2019 | 182,000.00 |
| Dec 31, 2018 | 149,000.00 |
| Dec 31, 2018 | 149,000.00 |
| Sep 30, 2018 | 313,000.00 |
| Sep 30, 2018 | 313,000.00 |
| Jun 30, 2018 | -121,000.00 |
| Jun 30, 2018 | -121,000.00 |
| Mar 31, 2018 | 163,000.00 |
| Mar 31, 2018 | 163,000.00 |
| Dec 31, 2017 | 388,000.00 |
| Dec 31, 2017 | 388,000.00 |
| Sep 30, 2017 | 88,000.00 |
| Sep 30, 2017 | 88,000.00 |
| Jun 30, 2017 | -171,000.00 |
| Jun 30, 2017 | -171,000.00 |
| Mar 31, 2017 | 288,000.00 |
| Mar 31, 2017 | 288,000.00 |
| Dec 31, 2016 | 429,000.00 |
| Dec 31, 2016 | 429,000.00 |
| Sep 30, 2016 | 274,000.00 |
| Sep 30, 2016 | 274,000.00 |
| Jun 30, 2016 | 23,000.00 |
| Jun 30, 2016 | 23,000.00 |
| Mar 31, 2016 | -74,000.00 |
| Mar 31, 2016 | -74,000.00 |
| Dec 31, 2015 | -124,000.00 |
| Dec 31, 2015 | -124,000.00 |
| Jun 30, 2015 | 410,000.00 |
| Jun 30, 2015 | 410,000.00 |
| Dec 31, 2014 | 150,000.00 |
| Dec 31, 2014 | 150,000.00 |
| Sep 30, 2014 | 10,000.00 |
| Sep 30, 2014 | 10,000.00 |